Ingrid Kelly is a Partner and member of the investment team at xista science ventures, an Austrian VC fund that invests in early-stage European deeptech and life science academic spinoffs and startups.
Ingrid holds a PhD in molecular biology from the University of Cambridge, is a qualified European Patent Attorney with experience in the pharma industry, and has been active since 2012 in technology transfer, spinoff creation and investments in life sciences startups.